Results
1 -
2 of
2
(Click
here to explore results)
- Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia. Khan Behlol Ayaz Ahmed, Santanu Kar Mahapatra, Mamilla R. Charan Raja, Shankar Subramaniam, Megarajan Sengan, Narendran Rajendran, Sandeep Kumar Das, Kuntal Haldar, Somenath Roy, Aravind Sivasubramanian, Veerappan Anbazhagan
, RSC Adv.
, 2016
, 6
, 18980
- Metabolic profiling study of shikonin's cytotoxic activity in the Huh7 human hepatoma cell line. E. D. Spyrelli, A. V. Kyriazou, C. Virgiliou, A. Nakas, O. Deda, V. P. Papageorgiou, A. N. Assimopoulou, H. G. Gika
, Mol. BioSyst.
, 2017
, 13
, 841